These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Somatostatinergic control of Kaposi's sarcoma growth through the inhibition of angiogenesis]. Corsaro A; Thellung S; Villa V; Arena S; Noonan D; Albini A; Schettini G; Florio T Minerva Endocrinol; 2001 Dec; 26(4):273-6. PubMed ID: 11782715 [TBL] [Abstract][Full Text] [Related]
3. Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities. Florio T; Morini M; Villa V; Arena S; Corsaro A; Thellung S; Culler MD; Pfeffer U; Noonan DM; Schettini G; Albini A Endocrinology; 2003 Apr; 144(4):1574-84. PubMed ID: 12639942 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine. Albini A; Morini M; D'Agostini F; Ferrari N; Campelli F; Arena G; Noonan DM; Pesce C; De Flora S Cancer Res; 2001 Nov; 61(22):8171-8. PubMed ID: 11719447 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Kaposi's sarcoma in vivo by fenretinide. Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128 [TBL] [Abstract][Full Text] [Related]
6. Anti-Kaposi's sarcoma and antiangiogenic activities of sulfated dextrins. Thornton M; Barkley L; Mason JC; Shaunak S Antimicrob Agents Chemother; 1999 Oct; 43(10):2528-33. PubMed ID: 10508038 [TBL] [Abstract][Full Text] [Related]
7. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Sgadari C; Barillari G; Toschi E; Carlei D; Bacigalupo I; Baccarini S; Palladino C; Leone P; Bugarini R; Malavasi L; Cafaro A; Falchi M; Valdembri D; Rezza G; Bussolino F; Monini P; Ensoli B Nat Med; 2002 Mar; 8(3):225-32. PubMed ID: 11875492 [TBL] [Abstract][Full Text] [Related]
8. Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts. Jia WD; Xu GL; Xu RN; Sun HC; Wang L; Yu JH; Wang J; Li JS; Zhai ZM; Xue Q J Cancer Res Clin Oncol; 2003 Jun; 129(6):327-34. PubMed ID: 12811549 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Dell'Eva R; Pfeffer U; Vené R; Anfosso L; Forlani A; Albini A; Efferth T Biochem Pharmacol; 2004 Dec; 68(12):2359-66. PubMed ID: 15548382 [TBL] [Abstract][Full Text] [Related]
10. Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody. Popkov M; Jendreyko N; McGavern DB; Rader C; Barbas CF Cancer Res; 2005 Feb; 65(3):972-81. PubMed ID: 15705898 [TBL] [Abstract][Full Text] [Related]